Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis

NCT02959658 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Primary Progressive Multiple Sclerosis

Interventions

DRUG: Dimethyl fumarate
DRUG: Placebo

Sponsor

Rigshospitalet, Denmark

Collaborators

[object Object]